RAD April 2023 Conference Abstracts and Posters

#365 - Phase 2 Trial in Progress — Lirentelimab in Adults with Moderate-to-Severe Atopic Dermatitis Inadequately Controlled by Topical Treatments

Cristian Rodriguez, Anesa Moyer, Alan T. Chang, Enoch Bortey, Craig Paterson

View Abstract
View Poster

#368 - Impact of a digital atopic dermatitis educational intervention on hispanic patients and family members

Luis F. Andrade , MaryJo Bekhash, Siri Choragudi, Juan M Gonzalez, Rodrigo Valdes, Gil Yosipovitch

View Abstract
View Video

#372 - Early insights into the characteristics of tralokinumab patients in a real-world setting in the United States

Raj Chovatiya, Sanjeev Balu, Yestle Kim, Amanda G. Althoff, Lawrence Rasouliyan

View Abstract
View Poster

#373 - Safety of lebrikizumab in adults and adolescents with moderate-to-severe atopic dermatitis: data from 8 trials

Linda Stein Gold, Diamant Thaçi, Jacob P. Thyssen, Melinda Gooderham, Vivian Laquer, Chitra R. Natalie, Fangyi Zhao, Eric Meskimen, Hany ElMaraghy, Sonia Montmayeur, Gemma Jimenez, Marjolein de Bruin-Weller

View Abstract
View Poster

#374 - Shared decision making for eczema patients and caregivers is not dependent on length of relationship with a provider or provider specialty

Allison R. Loiselle, Isabelle Thibau, Jessica K. Johnson, Wendy Smith Begolka

View Abstract
View Video

#375 - Understanding the effectiveness, utilization, and perceptions of action plans in adults and caregivers of children with atopic dermatitis

Jessica K. Johnson, Allison R. Loiselle, Wendy Smith Begolka

View Abstract
View Poster

#377 - Real-world use of OPZELURA™: safety analysis at 1 year

Wilson Hu, Michele Thornton, Robert A. Livingston

View Abstract
View Poster

#380 - Patients maintain stable response with no or minimal fluctuations during treatment with lebrikizumab up to week 52

Jonathan I. Silverberg, Andreas Wollenberg, Linda Stein Gold, Peter Lio, Jose Manuel Carrascosa, Gaia Gallo, Marta Casillas, Yuxin Ding, Sherry Chen, Helena Agell, Jacob P. Thyssen

View Abstract
View Poster
View Video

#381 - Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis

Jenny E. Murase, Raj Chovatiya, Lindsay Strowd, Jacob P. Thyssen, Christine Bangert, Amber Reck Atwater, Gaia Gallo, Laia Bardolet, Fan Yang, Jinglin Zhong, Delphine Staumont-Sallé

View Abstract
View Poster
View Video

#382 - Lebrikizumab provides clinically meaningful improvements in atopic dermatitis in patients previously treated with dupilumab

Linda Stein Gold, Jan Gutermuth, David N. Adam, Carsten Flohr, Stephan Weidinger, Amber Reck Atwater, Evangeline Pierce, Fan Emily Yang, Sherry Chen, Ignasi Pau-Charles, Lisa A. Beck

View Abstract
View Poster
View Video
Page 1 of 6
Results 1 - 10 of 60
© 2023 The Foundation for Dermatology Education.
The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.
Subscribe to Emails